학술논문
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
Document Type
Article
Author
Tap, W.D.; Healey, J.H.; Gelderblom, H.; van de Sande, M.; Palmerini, E.; Desai, J.; Bauer, S.; Blay, J.-Y.; Alcindor, T.; Ganjoo, K.; Martín-Broto, J.; Ryan, C.W.; Thomas, D.M.; Peterfy, C.; Gelhorn, H.L.; Shuster, D.E.; Wang, Q.; Yver, A.; Hsu, H.H.; Lin, P.S.; Tong-Starksen, S.; Stacchiotti, S.; Wagner, A.J.
Source
In: The Lancet . (The Lancet, 10 - 16 August 2019, 394(10197):478-487)
Subject
Language
English
ISSN
1474547X
01406736
01406736